SDPR inhibitors belong to a specialized class of chemical compounds that have garnered attention in the field of molecular biology and cell signaling research. SDPR, or Serum Deprivation Response Protein, is a cytoskeletal protein involved in various cellular processes, including actin filament dynamics, membrane remodeling, and cell adhesion. The term SDPR inhibitors refers to a group of molecules meticulously designed to selectively target and modulate the activity of SDPR. These inhibitors serve as invaluable tools in laboratory investigations, enabling researchers to explore the intricate molecular functions and cellular processes associated with SDPR.
SDPR inhibitors typically function by interfering with the interactions of SDPR with actin filaments, membrane components, or other cellular proteins, thereby affecting its role in various aspects of cell morphology, motility, and membrane dynamics. This interference can lead to alterations in cellular cytoskeletal organization, membrane structure, and cell adhesion, impacting various aspects of cell behavior and function. Researchers employ SDPR inhibitors to gain insights into the physiological roles and molecular interactions of SDPR within cells, aiming to advance our understanding of the fundamental mechanisms involved in cytoskeletal dynamics, membrane remodeling, and cell signaling. Through the study of SDPR inhibitors, scientists seek to unravel the complexities of cellular processes, cytoskeleton regulation, and the broader field of cell biology, contributing to our knowledge of how cells maintain their structural integrity and respond to extracellular cues.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin inhibits HMG-CoA reductase, potentially altering lipid composition and affecting membrane-associated proteins like SDPR. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Lovastatin, another HMG-CoA reductase inhibitor, could similarly influence membrane lipid dynamics and the expression of SDPR. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $75.00 $175.00 | 18 | |
Mevastatin is also an HMG-CoA reductase inhibitor, and it might indirectly alter SDPR expression by changing lipid homeostasis. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin inhibits cholesterol synthesis and could impact caveolae formation and, consequently, SDPR expression. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
Rosuvastatin lowers cholesterol biosynthesis, potentially influencing the cellular environment of proteins like SDPR. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Atorvastatin is known to reduce cholesterol levels, which might indirectly decrease SDPR protein expression or stability. | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $400.00 | 1 | |
Pravastatin, by modulating cholesterol synthesis, could affect the expression or localization of SDPR in the membrane. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
Progesterone interacts with steroid hormone receptors and may influence gene expression patterns, potentially including SDPR. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, could modulate signal transduction pathways and indirectly alter SDPR expression. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
GW4869 is a neutral sphingomyelinase inhibitor, and by altering lipid signaling, it could potentially reduce SDPR expression. | ||||||